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ABSTRACT OF THE THESIS
APTAMER-BASED ASSAY FOR DETECTION OF OCHRATOXIN A
by
Amanda Nicole Bartley
Florida International University, 2018
Miami, Florida
Professor John P. Berry, Major Professor
Ochratoxin A (OTA) is a potent mycotoxin found in a wide range of agricultural products
that has been linked to mitochondrial damage and renal disease. The standard methods
for OTA analysis currently rely on the use of high-performance liquid chromatography
(HPLC) coupled to fluorescence detection or mass spectrometry. Toward a highthroughput analysis of OTA, a single-stranded DNA aptamer, modified with a
fluorophore, coupled to a complementary sequence, modified with a FRET-based
quencher that dissociates in the presence of the target toxin, is proposed. In order to
integrate target trapping, aptamer immobilization methods were explored to mediate
interference issues. Assays were evaluated using wine and blood serum matrices. A
solution-based assay in a 96-well plate format provided a limit-of-detection of 2.7 ng/mL
which would be suitable for many of the proposed applications. Immobilized aptamer
formats, however, were not reliable, and a range of limitations to applications of the
assay were identified.
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CHAPTER 1: INTRODUCTION

Ochratoxin A (OTA) is a fungal mycotoxin that is produced as a secondary
metabolite of fungi belonging to the genera Aspergillus and Penicillium (1). Ochratoxin
A was first discovered by Vanderme et al., in 1965 (2). Structurally, OTA is
phenylalanine bound to a dihydroisocoumarin moiety through an amide bond (Figure 1).

Figure 1: Chemical structure of Ochratoxin A

Ochratoxin A is one of the most common mycotoxins found as an agricultural
contaminant of fruits and grains, and products of these (e.g., bread, beer, and wine).
Ochratoxin A is absorbed into the gastrointestinal tract and binds to plasma proteins. It is
excreted from the body with a half-life of about 35 days (1). Toxicologically, OTA is
hepatoxic, nephrotoxic, and mutagenic to mammals (3), and shown to have inhibitory
effects on several enzymes that use phenylalanine as a substrate (4), as well as to cause
mitochondrial damage. Epidemiologically, OTA has been linked to the Balkan Endemic
Nephropathy (BEN) renal disease (5). Linked to renal cancer, the International Agency
for Research on Cancer (IARC) has classified OTA as Group 2B, or a possible human
carcinogen (1) (5). However, there are few nations that have set regulatory standards to
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limit OTA presence in foodstuffs, such as Brazil, Israel, Switzerland, Uruguay, and the
European Union (1).
Wine is of a growing concern among agricultural products, shown to be
contaminated with OTA, because of increased consumption worldwide. Factors which
drive the occurrence of OTA in wine remain to be fully understood. The two most
common species of fungi found in grapes and wine are A. niger and A. carbonarius. It
was founded that these OTA producing fungi grow well under a wide pH range, 5.0-6.5,
and were influenced by water availability (6). Higher concentration and contamination
levels of OTA in red wines than white wines, from the same growing region, have been
reported and suggested to be related to wine making techniques: production of red wine
requires a mash (“must”) to be produced that includes the skin and pulp of grapes, while
white wines discard the skin, potentially increasing exposure to OTA (in skins) during the
fermentation process (7). Furthermore, climate was found to have possible effects on the
production of OTA: southern climates with dry, hot summers had an increased presence
(7). The European Union (EU) has established regulatory limits on OTA for wine, and
the EU regulatory limits prohibit levels above two parts-per-billion (2 ng/mL).
Additionally, the presence of OTA in human serum has been related to the
consumption of contaminated foods. Ochratoxin A binds to albumin with an unusually
high affinity, resulting in 99.5% of OTA in the circulatory system (8). Lino et al. (2008)
conducted a study of three areas in Portugal, collecting 104 serum samples, identifying
OTA concentrations between 0.14 and 2.49 µg/L based on the consumption of a variety
of contaminated goods (9). Furthermore, a correlation between certain medical issues,
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such as the Balkan Endemic Nephropathy and urinary system tumors, have been related
to an increase presence of OTA in foodstuffs and in serum levels. It was founded that
several factors affect plasma concentrations of OTA including person to person variation,
region variability, and seasonality (10).
The biosynthetic pathways of OTA have not been fully characterized and are
currently being investigated. Polyketide Synthase (PKS) and Non-Ribosomal Peptide
Synthetase (NRPS) are multimodular enzymes involved in the biosynthesis of many
secondary metabolites. The dihydroisocoumarin moiety of OTA (Figure 1) is believed to
be catalyzed by PKS. The dihydroisocoumarin is linked to L-phenylalanine via amide
bond, which is catalyzed by NRPS (11). Polyketides and non-ribosomal peptides are, in
fact, linked to many mycotoxins.

Analytical Methods for OTA
A variety of analytical methods have been explored for quantitative analysis of
OTA in various foodstuffs. The most common methods currently include enzyme-linked
immunoassays (ELISA), and methods based on high-performance liquid chromatography
coupled to either fluorescence detection (HPLC-FD) or mass spectrometry (HPLC-MS).
However, these methods often require extensive extraction and/or sample clean-up steps.
ELISA for OTA
There are multiple ELISA formats that have been used to detect OTA, the most
common being a “sandwich style” format. Detection in ELISA results from the
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interaction between antibodies and antigens specific to the target, (e.g., OTA) (12). In the
sandwich format, antigens representing the target (i.e., OTA) are immobilized to the
bottom surface of multiwell (e.g., 96-well) plates, and with the addition of an OTAspecific antibody, form a complex. Subsequently, a second antibody that is bound to a
“reporter” (typically colorimetric, e.g., horseradish peroxidase) enzyme is added, and free
OTA added to the well competes, in turn, with the antigen for the enzyme conjugate.
Upon addition of the colorimetric enzyme substrate, a color change results, and OTA can
be quantitated as an inverse relationship between concentration and color signal (13).
Although ELISA kits for OTA are commercially available, they can be relatively
expensive, and accuracy of the technique has frequently been suggested to be rather low.
Limits of detection for OTA by way of ELISA methods tend to be around 0.2 ng/mL,
fairly close to HPLC-FD methods. However, inter-assay coefficient of variation can
range from 4.78-16.67%. Additionally, it has been shown that there are several food
matrix effects that can interfere with ELISA, by way of non-specific interactions or cross
reactivity (14). Using wine as a sample matrix has, indeed, led to mixed results as there
are interfering species in wine, particularly including a range of phenolics, which may
interfere with antibody-binding (15). The addition of polyvinylpyrollidone (PVP) has,
therefore, been used for removing polyphenols, and reducing interferences (i.e., “false
positives”) in immunoassays (15).
HPLC-FD and HPLC-MS of OTA
High-Performance Liquid Chromatography (HPLC) enables analytical separation
of OTA from other components of sample matrices, and therefore, can increase
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selectivity and reliability. When coupled to fluorescence detection, HPLC-FD has shown
sensitive detection and quantitation of OTA in foodstuffs as low as 0.01-0.30 µg/kg
depending on sample matrices (16). In a recent study, a simplified liquid/liquid
extraction (LLE) method – eliminating more extensive sample preparation and clean-up
steps - was developed and applied to HPLC-FD detection OTA in wine, De Jesus et al.
(2018). In this method, De Jesus et al. (2018) used simple extraction with chloroform
(followed by concentration in vacuo) which was found to be sufficient for recovery of
OTA, and subsequent HPLC-FD. The method achieved LOD and LOQ of 0.1 and 0.3
µg/L, respectively, and was applied to 41 wine samples sourced from the United States,
showing that more than 85% (of the 41 wines tested) were above the LOD (0.1 µg/L),
and 31 of these OTA-positive wines were above the LOQ (0.3 µg/L) (17). The sensitivity
of this simple LLE is, therefore, well below the EU’s regulatory limit of 2 ng/mL in wine,
and can be classified as “quick, easy, cheap, effective, rugged, and safe” (QuEChERS).
High-Performance Liquid Chromatography coupled to Mass Spectrometry
(HPLC-MS) has been used as a confirmatory method for the detection of OTA and, in
fact, multi-mycotoxin analysis in foodstuffs (18). Typically, 13C-labeled internal
standards are used to compensate for matrix effects when identifying and quantifying
mycotoxins by this technique. As an example of using 13C-labeled internal standards, AlTaher et al. (2013) surveyed 143 red and white wines from 4 major growing regions by
means of a simple dilution of wine (and beer) at a 1:5 ratio, and subsequently injected
into the UHPLC-MS/MS system for multi-mycotoxin analysis (19). It was founded that
OTA, among other mycotoxins, were affected by ion enhancement with spiked white
wine samples. The methodology applied in this study shows that the LOD and LOQ
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values for both red and white wine were 0.1 and 0.5 ng/mL, respectively, and are well
below the EU’s regulatory limit of 2 ng/mL (19).

Aptamer-Based Analysis for OTA
An increasing number of studies have utilized aptamers for detection of OTA and
a wide range of analytical applications. Aptamers derive from the Latin word aptus, “to
fit”, and are typically single or double stranded oligonucleotides. Aptamers bind to a
specified target molecule and are more chemically stable and cost effective than
antibody-based (i.e. ELISA) methods. Aptamers are created through a process known as
SELEX, or Systematic Evolution of Ligands by Exponential Enrichment (20). An
aptamer sequence, specific for OTA, was previously identified by Cruz-Aguado et al.
(2008) by way of SELEX. The aptamer sequence is 5′-GAT CGG GTG TGG GTG GCG
TAA AGG GAG CAT CGG ACA-3’ (21). Most analytical methods employing aptamers
for OTA detection and quantitation utilize this aptamer sequence with few modifications.
Gold Nanoparticles
Assays for OTA detection and quantitation using aptamers bound to gold
nanoparticles (AuNPs) have been previously developed (22) (23) (24). Gold
nanoparticles are colorimetric indicators whose size and dispersion changes in the
presence of salt, resulting in a measurable color shift from red to blue. In assays, targetspecific aptamers are bound to the surface of an AuNPs, and in the presence of OTA, a
structural change occurs revealing the AuNP’s surface, allowing interactions with salts,
and therefore, the corresponding quantifiable color change (2). As an example, a study
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conducted by Luan et al. (2015) developed an assay using AuNP’s and a cationic
polymer, polydiallyldimethylammonium chloride (PDDA) to colorimetrically detect
OTA in Chinese distilled liquor. In this assay, the OTA aptamer is free to form a duplex
with PDDA in the absence of OTA, and therefore, no color change will occur. However,
when OTA is present, the aptamer forms a “G-quadruplex” structure, and PDDA
aggregates the AuNP’s. The reported linear concentration range for this assay is 0.0550ng/mL with an LOD of 0.009ng/mL (23).
Direct Detection of OTA by Aptamers in Solution
Assays that use the direct interaction between OTA and aptamers in solution was
recently developed by Chen et al. (2012). The assay specifically utilizes a so-called
“structure switching,” aptamer formation in which a signaling aptamer specific for OTA,
bound to a fluorophore (i.e., fluorescein, or FAM) is paired with a quencher (i.e.,
TAMRA) modified complementary sequence. Upon addition of OTA, a conformational
structure change occurs, therefore, displacing the complementary quencher sequence, and
enabling emission of the fluorescent signal (Figure 2) (25).
The basic premise of the assay is as follows: two DNA oligomer sequences - the
aptamer and complementary “quencher” strand - form a duplex (following heating and
cooling). Through a FRET-based mechanism, the quencher strand (via TAMRA
modification) attenuates the emission of fluorophore (i.e., FAM) on the aptamer
sequence, thus resulting in a very low level of base fluorescence. Aptamers, in turn, have
the ability to form a complex with the target (i.e., OTA) allowing a conformation change.
Specifically, upon addition of the target OTA, the fluorophore-modified aptamer strand
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forms the complex with the target, and releases the quencher strand (Figure 2) enabling a
measurable increase in fluorescent emission.

Figure 2: Depiction of conformation change of aptamers with addition of OTA.

Chen et al. (2012) indicated that the fluorescent signal is linear from the range 1
to 100 ng/mL with a reported limit of detection (LOD) of 0.8 ng/mL. The repeatability of
the assay, using the relative standard deviation (RSD), was reported as 2.4% and
reproducibility (reported an RSD of eight separate samples with the same concentration)
was 4.7%. Selectivity was measured by adding other mycotoxins, including aflatoxin B1
and zearalenone, and the structurally related ochratoxin B (OTB), into the mixture, and
measuring fluorescent intensity. The addition of OTB resulted in a slight increase in
fluorescent intensity, while aflatoxin B1 and zearalenone effects were negligible (25).
Immobilization of aptamers
A number of approaches have employed immobilization of aptamers, for a wide
range of matrices, as part of assay formats. Immobilization has the potential for target
“trapping,” and consequently integrated sample clean-up alongside detection.
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One such strategy is immobilization of aptamers on 96-well (or other multiwell)
plates enable a high-throughput format similar to ELISA. Demirkol et al. (2016) created a
fluorescence assay using 96-well microtiter plates with immobilized aptamers to detect E.
coli. In this case, 96-well plates coated with poly-l-lysine were specifically used to
immobilize thiol-modified aptamers by way of sulfo-SMCC (sulfosuccinimidyl-4-(Nmaleimidomethyl) cyclohexane-1-carboxylate) cross-linking chemistry. Sulfo-SMCC
reacts with the NH2 groups from poly-l-lysine, and forms a maleimide activated carrier,
and upon addition of the thiol-modified aptamers, in turn, a carrier-aptamer conjugate is
formed, thereby covalently linking the aptamers to the solid support. Addition of E. coli
and concurrently quantum dots, enabled fluorescent detection (26).
Specifically relevant to the current study, Duan et al. (2011) created an aptamerbased assay for detection of OTA whereby two complementary strands, including one
(Seq1) immobilized by way of avidin/biotin binding, and one (Seq2) labeled with
fluorescent (i.e., FAM) reporter, were effectively used to measure OTA (27). In the
absence of OTA, a strong background fluorescent signal was measured. In the presence
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of OTA, Seq1 was bound to the OTA, therefore releasing some of Seq2, and resulting in
a decrease in fluorescent signal, shown in Figure 3.

Figure 3: Depiction of Duan, et al. (2011) methodology, whereby a high fluorescent signal is present in the
absence of OTA, and a decrease in signal results upon addition of OTA and release of FAM modified
strand.

The LOD of the assay was calculated to be 0.01 ng/mL, or 0.01 ppb (well below
the EU regulatory guidelines). The authors mention that binding of OTA to aptamers
relied heavily on Mg2+ and Ca2+ ions and less of K+ (as reflected in the buffers used) (27).
Objectives
The use of fluorescently labeled aptamer, paired with complementary quencher,
as described in previous studies (25), was adapted in the current study to develop a
multiwell, (i.e., 96-well), plate format assay for OTA. The advantage to using a 96-well
plate is the ability to perform multiple analyses at the same time with measurements by a
plate reader. The present research, specifically, utilizes aptamer sequences and
fluorophore/quencher pairs (i.e., FAM/TAMRA), employed in this and other (27),
studies.
In addition, the use of immobilization techniques (for multiwell microtiter plates)
as described in previous studies (26), (27), were, in turn, explored as a means of
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developing a functional assay, whereby sample preparation (i.e., “clean-up”) could be
integrated alongside detection. Approaches included the use of sulfo-SMCC cross-linker
chemistry to covalently immobilize, and biotin/avidin interactions to non-covalently
immobilize, aptamers to assay plates.
Finally, the use of the developed assays, in turn, was assessed with respect to
OTA in multiple relevant matrices. These included wine, as a representative (and
increasingly relevant) agricultural product known and described above. In addition,
blood serum – and specifically commercially available fetal bovine serum – was
investigated towards adapting the technique for biomedical applications. This aspect of
the study enabled both operational assessment of the assay, and evaluation of the
potential for a practical application.
Accordingly, this study had the following specific aims:
Aim 1: Develop a multiwell plate format aptamer-based assay, specifically using
fluorescence/quenching, for OTA detection and measurement
Aim 2: Develop a multiwell plate format assay that uses an immobilized aptamer, and
fluorophore/quencher interactions, for “target trapping” prior to detection and
measurement of OTA
Aim 3: Evaluation of the developed assay for detection and measurement of OTA in
relevant matrices including wine and blood serum
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CHAPTER 2: AN APTAMER-BASED MULTIWELL PLATE ASSAY FOR OTA
Introduction
Aptamers, previously described in the literature, have been shown to be highly
specific and increasingly sensitive for target detection. When coupled to a multiwell plate
format, the assay allows high-throughput analysis of samples with relatively simple
instrumentation (i.e., plate reader). Figure 4 depicts the proposed assay format from the
view of a single well. The fluorophore and quencher modified sequences form a duplex
structure with relatively low fluorescent signal (Figure 4). Upon addition of the target,
OTA, the fluorophore and quencher modified sequences dissociate, and the fluorophore
modified sequence forms a “G-quadruplex” structure with OTA, while the quencher
sequence remains in solution (Figure 4).

Figure 4: Proposed multiwell in solution aptamer-based assay

The G-quadruplex structure has been described as the proposed folding
mechanism, due to high amounts of guanine bases in the aptamer sequence. Gquadruplex structures have been shown to have increased sensitivity and selectivity.
Basic G-quadruplex structures rely on hydrogen bonding and presence of certain metal
ions such as as potassium (K+) and sodium (Na+) (28).
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The fluorophore modified aptamer (e.g., FAM) and the complementary quencher
(e.g., 10 base pair TAMRA modified) sequence that showed the lowest signal to noise
ratio in the Chen et al. (2012) study were selected to create a multiwell plate assay for the
detection and quantitation of OTA. Furthermore, the optimum molar ratio between
fluorophore modified aptamer and quencher sequences (1:3) were considered for
adequate quenching of the duplex (25).
Materials and Methods
Materials
Fluorophore and quencher modified aptamer sequences were purchased from
Integrated DNA Technologies (IDT) in Coralville, Iowa with HPLC purification. The
fluorophore modified sequence was 5’- GAT CGG GTG TGG GTG GCG TAA AGG
GAG CAT CGG ACA-FAM-3’, and the quencher modified sequence was 5’-TAMRATGT CGG ATG C-3’.
Corning™ Falcon™ 96-well black/clear tissue culture treated plates were
purchased from Fisher Scientific. Greiner Bio-One 96-well black/black plates were
purchased from VWR International. Trizma® hydrochloride (Tris-HCl), potassium
chloride (KCl), and calcium chloride (CaCl2) were purchased from Sigma-Aldrich (St.
Louis, MO). Sodium chloride (NaCl) was purchased from Fisher-Scientific (Hampton,
NH). Water was purified with a Labconco Water Pro PS system at 18.2 megaohms.
Ochratoxin A, 99+% was purchased from ACROS Organics™. Oligonucleotides and
OTA stored -20 ͦC.
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Instrumentation
Measurements were taken on a Tecan Infinite® M1000 microplate reader with
excitation 495nm and emission 520nm. The gain was set to automatically adjust
according to the well with the highest signal (100nM aptamer only), and the z-position
was automatically set based on scanning volume in wells.
Assay Procedure
Stock solutions of the fluorophore modified sequence were made to 10uM and
quencher modified sequence to 20uM with addition of purified water. The binding buffer
used for the reaction between duplex and OTA was same as Chen et al. (2012) reported:
10 mM Tris, pH 8.5, 120 mM NaCl, 5 mM KCl, and 20 mM CaCl2 (25). Stock solutions
of OTA were prepared by initially dissolving in methanol, and subsequent dilution in
binding buffer to give final concentrations (when diluted 50-fold into test wells)
equivalent to 1, 2, 5, 10, 15, 20 and 30 ng/mL.
A range of aptamer concentrations (2.5, 5, 10 and 20 pmol per well) were
evaluated; however, a final concentration of 5 pmol per well of fluorophore modified
aptamer was found to be sufficient to generate a linear response in the range of 1-20 ppb
OTA. Likewise, a 1:2 molar ratio of aptamer to quencher was found to be similarly
efficient to 1:3 molar ratio employed by the Chen et al. (2012) study, in terms of low
background fluorescence, and used in the present study. The final working volume of the
assay was 50 µL with a 1:2 molar ratio (or 100nM:200nM of fluorophore- to quenchermodified sequences). To prepare the equivalent volume of duplex for each well, 0.5 µL
of fluorophore strand (10uM) and 0.5 µL of quencher strand (20uM) were added (in a
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500 µL Eppendorf tube) to 48 µL of binding buffer. The duplex was heated to 88 °C for 5
minutes and cooled at room temperature for 30 minutes. The duplex (49 µL) was added
to the 96-well plate, and initial measurements were taken in 1-minute intervals for 10
minutes (stability of signal). Next, OTA was added (1 µL) to each well with final
concentrations ranging from 1, 2, 5, 10, 15, 20, 30 ng/mL (i.e., 1 µL diluted in 49 µL of
assay buffer). Measurements were taken in 1-minute intervals over 10 minutes with the
first measurement made within 60 seconds of addition of OTA to the assay.
Calculations and Statistical Analyses
All data were normalized, subtracting the buffer control signal, therefore,
reducing the percent change in fluorescent intensity influenced by the buffer composition.
The percent change in fluorescent intensity (RFU) was calculated as [(finalinitial)/initial]*100. The LOD was calculated as 3*(std. error of y-values/slope) and the
LOQ as 10*(std. error of y-values/slope). The reproducibility and repeatability were
measured by the %RSD or the (standard deviation/mean) *100. The accuracy was
measured by comparing the measured value to the actual value as a percentage of error.
Subsequent, ANOVA and t-tests were conducted using Excel, data shown in
corresponding Appendices.
Results
A concentration-dependent increase in the percent change in fluorescence was
observed over the range of 1 to 10 ng/mL OTA, and a linear (R2 = 0.9648) relationship
was observed from 1 to 20 ng/mL (Figure 4). The method was further validated in terms
of sensitivity (i.e., LOD and LOQ) and precision including reproducibility and
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repeatability (Table 1). Limits of detection and quantitation were calculated as 2.7 ng/mL
and 8.9 ng/mL, respectively. The accuracy was measured as a 2.65% error, comparing
the expected and the true experimental values. The reproducibility (n = 8, 10 ng/mL) was
calculated as a RSD% of 8.8%, whereas repeatability (n = 10, 10 ng/mL) was measured
as a RSD% of 5.9% (Table 1).

Figure 5: Bar graph showing increasing change in fluorescent intensity with increasing concentration,
with calibration including dynamic range (0-10ng/mL)
Table 1: Figures of Merit for solution-based assay

Figures of Merit
LOD
2.7 ng/mL
LOQ
8.9 ng/mL
Reproducibility 8.8% RSD
Repeatability
5.9% RSD
Accuracy
2.65% Error
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Analysis of Variance (ANOVA) was conducted to determine whether there were
significant differences between the percent change in fluorescent signals of spiked OTA
concentrations. The normality of the variables were tested using Kurtosis and Skewness
values, verifying that Kurtosis values between ± 2 and the Skewness values between ± 1.
The subsequent ANOVA output for the comparison of group means of 0, 1, 2, 5, 10, 15,
20 ng/mL with 5 replicates is shown in Appendix 2: Table 5. The null hypothesis is that
all group means are equal. The F value is greater than the critical value of F meaning that
the null hypothesis is rejected (15.49 > 2.45). Furthermore, the p-value is 9.39 x 10-08 <
0.05 indicating a significant difference between group means, or percentage change in
fluorescent signal. Additional t- tests were performed to determine which groups were
different from each other. Appendix 2: Table 6 shows the t-test results for the comparison
of the percent change in fluorescent intensity signal for 0 and 1 ng/mL and the percent
change in fluorescent intensity signal for 1 and 5 ng/mL. The p-value for the t-tests
comparing 0 and 1 ng/mL and 1 and 5 ng/mL were 0.0366 < 0.05 and 4.88 x 10-08 < 0.05,
respectively, depicting a significant difference in the percent change of fluorescent signal.
Furthermore, Appendix 2: Table 7 shows the t-tests for the comparison of 1 and 15ng/mL
(left) and the comparison of 1 and 20ng/mL (right) with p-values 0.0683 > 0.05 and 7 x
10-07 < 0.05, respectively. The p-values chosen are the ones for the two-tailed test which
determines if there is any significant difference between the signals, including both
greater than or less than. The difference between 1 and 15ng/mL was shown as not
significant; however, the value was significant for the one-tailed test (0.0341 > 0.05).
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Discussion
The aptamer-based method developed in the present study demonstrated a
concentration-dependent fluorescent response for detection and quantitation of OTA with
sensitivity which is potentially sufficient for agricultural and biomedical applications.
The LOD and LOQ for the solution-based assay of spiked OTA samples were 2.7 ng/mL
and 8.9 ng/mL, respectively. The EU’s regulatory guidelines prohibits levels in wine, for
example, is currently 2 ng/mL, and the developed method would enable detection at this
limit. On the other hand, current guidelines for OTA in various commodities for the
United States, Canada, and the European Union are depicted in Table 2. The United
States does not currently have regulations or maximum limits on OTA in foodstuffs.
However, both Canada and the European Union have implemented limits using current
and past research. Both Canada and the European Union have limits at 3 ng/mL for grains
of direct consumption and cereal products.
Table 2: Maximum concentrations for commodities as provided by the United States (no guidelines),
Canada (29), and the European Union (30).

Max concentration (ng/mL)
Commodity
United States Canadaa European Union b
Grains- direct consumption
3
3
Derived cereal products
3
3
Cereal food for infants
0.5
0.5
Dried vine fruit
10
10
Roasted coffee
5
Grape juice and related products
2
2
Wine
2
a

Canada Proposed Maximum Limits 2009

b

European Commission Maximum Levels 2006
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Additionally, a study testing OTA in serum was conducted by Malir et al. (2013)
with 100 pregnant women in their first trimester, ages 19-40 years, in the Czech
Republic. The blood serum levels were tested by HPLC-FD and compared with dietary
consumption. The range of incidence of OTA in blood serum was between 0.1-0.35
ng/mL, with an average of 0.15 ng/mL. However, these values are similar to those who
were not pregnant and eating comparable foodstuffs, indicating the relationship between
contaminated foods and serum levels (31). Furthermore, urine has been used as a matrix
to measure OTA levels in humans. Pascale et al. (2001) measured spiked human urine
levels between 0.05-1ng/mL by HPLC-FD (32).
The LOD/LOQ for the current assay were, however, lower than previously
reported by Chen et al. (2012) for a similar approach (i.e., 0.08 ng/mL). Potential
explanations for the higher values (and lower sensitivity) may be related to the difference
between the optical capabilities of the two formats (i.e., use of a cuvette versus a 96-well
plate format). More specifically, it may be affected by the plates used. There are, in fact,
a variety of microtiter plates for 96-well plate assays. However, black plates with black
(i.e., opaque) or clear bottoms are most often used for fluorescent assays. Both
black/black and black/clear plates were tested in the current study to observe differences
in percentage change of fluorescent intensity by way of bottom or top read. The solutionbased assays used black plates with clear bottoms and the immobilized assays used black
with black plates. Precision of the assay was estimated by taking measurements to
calculate reproducibility and repeatability. The reproducibility (%RSD) of the assay was
determined to be 8.8% whereas repeatability was 5.9%, and may be, likewise, dependent
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upon the optics and precision of the instrumentation, i.e., plate reader (discussed further
in Chapter 3).
The concentration of fluorophore modified aptamer was also tested at a range of
concentrations including 2.5, 5, 10, and 20 pmol per well. The 5 pmol/well concentration
was chosen in the study because it had the most stable and linear increase in relationship
among various spiked OTA concentrations, whereas 2.5 pmol/well concentration of
fluorophore-modified aptamer did not show a significant difference between aptamer and
duplex signals. Additionally, 10 pmol and 20 pmol concentrations were tested, however,
5 pmol was found to be similarly efficient in terms of detection of spiked OTA in
relevant ranges of concentrations (Figure 7). The result agrees with the previous studies,
Chen et al. (2012), which employed an equivalent concentration of fluorescently labeled
aptamer. The Duan et al. (2011) study uses 50nM concentration of aptamer, however,
fails to mention the working volume of the assay. Finally, the larger distinction between
0-5 ng/mL in the 5pmol concentration provides the opportunity for greater sensitivity
between those concentrations.
Taken together, these results suggest that the proposed assay may, in principle,
provide a format suitable for high-throughput detection of OTA. To further assess this
potential, relevant matrices must be assessed. However, anticipating a potential
contribution of interfering species within these complex biological matrices, I first
investigated the possible use of aptamer immobilization within the current assay format
as a means of integrated sample preparation via “target trapping” (Chapter 3).
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Figure 6: Comparison of fluorophore-modified aptamer pmol concentrations
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CHAPTER 3: A MULTIWELL PLATE ASSAY FOR OTA BASED ON
IMMOBILIZED APTAMER
Introduction
Modification of the aptamer fluorescence quenching assay (as discussed in
Chapter 2) based on the immobilization of the OTA-specific aptamer was investigated. It
was proposed that immobilization of aptamers would enable a simplified and integrated
sample preparation and clean-up by removal of potential interferences by way of targettrapping and subsequent washing steps. The proposed approach is depicted in Figure 7,
where the duplex is immobilized to 96-well test plates by way of cross-linker (i.e., biotinavidin or thiol chemistry), and upon addition of OTA, the quencher strand is released,
and can be removed (by washing), to enable specific measurement of fluorescent signal
generated by presence of OTA.

Figure 7: Depiction of immobilization of fluorophore/quencher sequence

Three sets of aptamer configurations and immobilization techniques were
explored in which the fluorophore modified sequence was immobilized by either thiolbased (i.e., SMCC) chemistry at the 5’ end, or by biotin modifications at either the 5’ or
3’ ends (see Appendix 1).
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Materials and Methods
Materials
Aptamer sequences modified with fluorophore (FAM) and quencher (TAMRA),
and modifications (i.e., thiol and biotin) were purchased from Integrated DNA
Technologies (IDT) in Coralville, Iowa with HPLC purification. The fluorophore-labeled
sequences were as follows: 5’-/Biotin-TEG/GAT CGG GTG TGG GTG GCG TAA
AGG GAG CAT CGG ACA-FAM-3’ (5BIOTIN), 5’-/56-FAM/ TGA TCG GGT GTG
GGT GGC GTA AAG GGA GCA TCG GAC A /3BioTEG/-3’ (3BIOTIN), and 5’/ThioMC6-D/ GAT CGG GTG TGG GTG GCG TAA AGG GAG CAT CGG ACA/36FAM/-3’. The quencher sequences were as follows: 5’-TAMRA-TGT CCG ATG C-3’
(5TAMRA) and 5’ CCC ACA CCC GAT T /36-TAMSp/-3’ (3TAMRA).
Pierce™ Streptavidin Coated High Capacity Plates, 96-well plates, black/black
were purchased from ThermoFisher Scientific and stored at -20 ̊C. Corning Poly-D-lysine
coated 96- well polystyrene plates, black/clear were purchased from Sigma Aldrich (St.
Louis, MO). Chemicals including magnesium chloride (MgCl2), tris(2-carboxyethyl)
phosphine (TCEP), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES),
Trizma® hydrochloride (Tris-HCl), potassium chloride (KCl), and calcium chloride
(CaCl2) were purchased from Sigma-Aldrich (St. Louis, MO). Sodium Chloride (NaCl)
and Sulfo-SMCC No-Weigh Format (8 X 2mg microtubes) were purchased from FisherScientific (Hampton, NH). Water was purified with a Labconco Water Pro PS system
(18.2 megaohms). Ochratoxin A, 99+% was purchased from ACROS Organics™.
Oligonucleotides and OTA stored -20 ͦC.
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Instrumentation
Measurements were taken on a Tecan Infinite® M1000 microplate reader with
excitation 495 nm and emission 520 nm. The gain was set to automatically adjust using
the well with the highest signal (100 nM aptamer only), and the z-position was
automatically set based on scanning volume in wells. Additionally, comparative
measurements were taken on a Biotek Synergy HT or Biotek Synergy 2 plate-reader,
specifically using filters for 485/20 nm excitation and 528/20 nm emission. Likewise, the
gain was set on these instruments to the well with the highest signal (100 nM aptamer
only), and subsequently used throughout the procedure.
Immobilization of Aptamers
Aptamers were immobilized on 96-well plates using either biotin/streptavidin
interactions, or covalent linkage via sulfo-SMCC reaction with poly-D-lysine coating on
plates. Both approaches were subsequently evaluated in assays of OTA.
For biotin-modified aptamers, an excess of quencher (1:2 molar ratio for
fluorophore to quencher aptamer) was used; accordingly 0.5 µL of 10 µM 5BIOTIN or
3BIOTIN aptamer, and 0.5 µL of 20 µM of 5TAMRA or 3TAMRA quencher strand were
combined in a 500 µL Eppendorf tube, with 49 µL binding buffer. Stock solutions (10
µM biotinylated aptamer, 20 µM TAMRA-modified quencher) were prepared in
sterilized water, and stored at -20 ̊C. The binding buffer used for 5BIOTIN/5TAMRA
was 10 mM Tris, pH 8.5, 120 mM NaCl, 5 mM KCl, and 20 mM CaCl2, the same as the
solution-based assay. The binding buffer for 3BIOTIN/3TAMRA was 10 mM HEPES,
120 mM NaCl, 5 mM KCl, 20 mM MgCl2, 20 mM CaCl2, pH 7.0. Aptamer/quencher
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mixtures were heated to 88 ̊C for 5 minutes, and allowed to cool for 30 minutes at room
temperature, to form duplexes. The duplex (50 µL) was subsequently added streptavidincoated plate, and incubated for 60 min at room temperature.
Secondarily, an immobilization procedure using poly-lysine and sulfo-SMCC was
investigated (26). TCEP (1mM, IDT recommendation 100x excess) was used to break the
disulfide bonds on the thiolated aptamer, and prepare aptamer for subsequent
immobilization. A solution of sulfo-SMCC (2 mg/mL) in water was prepared, and 50 µL
of this solution was added to each well of a poly-D-lysine coated, 96-well plate, which
was placed on a rotary shaker for 2 hours at room temperature. Wells were rinsed with
water, and allowed to dry. Following similar procedures as used for biotin-modified
aptamers, a 1:2 molar ratio of fluorophore modified sequence (0.5 µL of 10 uM solution),
to quencher modified sequence, (0.5 µL of 20uM solution) were added to a 500 µL
Eppendorf Tube with 10 mM Tris, pH 8.5, 120 mM NaCl, 5 mM KCl, and 20 mM CaCl2
binding buffer (49 µL). The aptamers were incubated on plates overnight at room
temperature before being used for assays.
Assay Procedure
Aptamer assays were generally conducted similar to the technique described in
Chapter 2. Measurements (n=10) of immobilized duplexes were taken at 1-minute
intervals for 10 minutes to acquire the initial fluorescent readings. The wells, containing
immobilized aptamers, were then washed with 0.01M PBS, and refilled with binding
buffer. Measurements (n=10) at 1-minute intervals were then taken to determine the
change in signal due to possible loss of non-immobilized following washing step. Finally,

25

1 µL aliquots of OTA, prepared at a range of concentrations (0-20 ppb) were added to the
test wells, and a final set of 10 measurements (at 1-minute intervals) were made.
Calculations and Statistical Analyses
All data were normalized by subtracting the buffer control signal, therefore,
reducing the percent change in fluorescent intensity influenced by the buffer composition.
The percent change in fluorescent intensity (RFU) was calculated as [(finalinitial)/initial]*100. Subsequently, ANOVA and t-tests were conducted using Excel
(output of these analyses are shown in corresponding Appendices).
Results
To show that the quenching mechanisms work for the immobilization procedures
of 5BIOTIN and 3BIOTIN, the relative fluorescent units were compared for the aptamer
signal, the buffer signal, and the duplex signal (aptamer and quencher combined). Figure
8 shows the fluorescence of aptamer with and without quencher from 10 measurements.
When the aptamer and quencher sequences are added together, a significant reduction in
fluorescence was observed, and approached the signal intensity of buffer-only controls.

Figure 8: Quenching mechanism significantly reduces RFU for 5BIOTIN assay (left) and 3BIOTIN assay
(right).
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Figure 9 shows the calculated percent change in fluorescent intensity upon
addition of spiked OTA, in methanol, to 5BIOTIN/5TAMRA duplex. A single factor
ANOVA was used to assess the significant differences in the percent change of
fluorescent intensity across various concentrations (0, 1, 5, 10, 20 ng/mL). The ANOVA
provided a p-value of 0.3211 > 0.05, showing that there was no significant difference
among percent change in fluorescent intensity for various concentrations (Appendix 3:
Table 8).

Figure 9: Change in relative fluorescent intensity upon addition of OTA to immobilized aptamers

To further investigate, the 5BIOTIN assay was evaluated on a similar (Biotek 2)
instrument. Figure 10 shows that the change in fluorescent intensity was found to
increase, but all measurements curiously represented negative changes in fluorescence.
Potential reasons for this negative change in fluorescence could include the
conformational change of the aptamers upon addition of the OTA was unsuccessful or
there were instrumental issues.
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Figure 10: 5BIOTIN assay with increasing change of fluorescent intensity.

Immobilization and assay procedures were next conducted for
3BIOTIN/3TAMRA in duplicate. Figure 11 shows the relative change in fluorescent
intensity for 0, 1, 5, 10 and 20 ng/mL OTA. An apparent effect on concentration on
fluorescence response was observed over this range. An ANOVA single factor was
conducted to test if there were any significant differences between concentrations,
however, the p-value 0.196 > 0.05 indicated no significant difference among the
percentage change in fluorescent intensity (Appendix 3: Table 9).
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Figure 11: Change in fluorescent intensity of 3BIOTIN

Two buffers, namely TRIS and HEPES, were evaluated in the 5BIOTIN assay
(Figure 12). Results confirmed a lack of concentration-dependent increase in
fluorescence, as expected for the proposed assay, and moreover, showed no significant
difference between the two buffers. A two-factor ANOVA was performed to analyze the
statistical significance of Tris vs. HEPES buffer on each of the assays respectively
(Appendix 3: Table 10). The p-value for concentration was 0.6506 > 0.05, concluding
that there was no significant difference in the percent change of fluorescent intensity in
concentrations for the two buffers. Furthermore, the p-value for the percent change in
fluorescent intensity comparing buffers among concentrations was 0.4123 > 0.05,
concluding the buffers were not statistically different. Lastly, the p-value for the
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interaction between concentration and buffer was 0.1112 > 0.05, indicating there is no
significant interaction between concentration and buffer type (Tris vs. HEPES).

Figure 12: Comparison of HEPES and Tris buffers used in 5Biotin assay

Finally, immobilization of thiol-modified aptamer via SMCC-linking chemistry
was investigated. However, the duplex did not appear to effectively immobilize to the
bottom of the well, and washed off during the 1st and 2nd washing steps (PBS1, PBS2) as
shown in Figure 13. The readings after each washing step show a significant decrease in
signal from binding buffer (BB) to PBS1 and PBS 2, where almost a complete loss of
relative fluorescent signal was observed.
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Figure 13: Average relative fluorescent units (RFU) indicating loss of fluorescent signal over two washing
steps

Discussion
Fluorescence response of the immobilized 5BIOTIN/5TAMRA duplex did not
indicate a linear relationship with OTA concentration upon initial assessments (Figure 9).
The average percent change in fluorescent intensity for 0, 5, and 10 ng/mL spiked
samples resulted in values of 12.92, 13.11, and 13.88%. This indicates a lack of
concentration-dependent relationship with OTA. Additionally, the standard deviation for
the percent change in fluorescent intensity of 20 ng/mL provides a range of signal from
12-50%, indicating the lack of sensitive detection, overlapping with the concentrations 0,
5, and 10 ng/mL (Figure 9). When testing the 5BIOTIN assay on a separate plate reader
(Figure 10), all signals were negative with decreasing negativity as concentrations
increased. Reasons for this could be instrumentational issues or that the quencher is
working incredibly well, so the conformational change upon addition of OTA and
subsequent fluorescent signal, was being quenched.
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Upon further review of the Duan et al. (2011) study, I decided to incorporate the
approach of heating the 96-well plate prior to assays. Heating aptamers enables
unraveling and opening of conformational structure to assist in the binding of OTA and
displacement of the quencher strand. Due to instrumentation downtime, this method was
not attempted on the Tecan M100 Infinite, but instead evaluated on a Biotek Synergy HT
plate reader. Upon heating this assay for 40 minutes at 45 ͦC and using the relevant
percentage change in fluorescent intensity calculation, no significant change in
fluorescent signal with increasing OTA concentration was detected. The percentage
change in fluorescent signal for the duplex with 0 ng/mL OTA increased, more so than
those duplexes spiked with 1, 5, 10, and 20 ng/mL OTA. The reason for this is unknown,
but it is possible that the heating step dissociated some portion of the quencher from this
duplex, therefore, increasing the fluorescent signal upon measurement.
Based on the lack of success of the 5BIOTIN assay, an alternative aptamer
configuration was evaluated, specifically the addition of the biotin modification to the 3’
was investigated (3BIOTIN). However, similar results were achieved in which a lack of
concentration-dependency was noted.
Optically, the immobilization of aptamers to the bottom of a multiwell plate may
restrict the emitted fluorescent signal, in terms of the solution dynamics within the test
well. The excitation wavelength in this case needs to travel through the solution to the
bottom of the well, potentially posing interference or scattering effect before reaching the
aptamer duplexes. The distribution of duplexes on the bottom of the well is not known, or
characterized here, and may limit emission and, thus, measured signal.
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Changing the aptamer configuration to a biotin modification on the 3’ end, and
the fluorophore modification to the 5’ end, required a new quencher sequence that would
be complementary. As the quencher for the solution-based assay and the 5BIOTIN assay
appeared to be functional, a similar complementary 13-base pair sequence was selected
for the 3BIOTIN assay. Although a 10-base pair sequence would have been more similar
to the 5BIOTIN assay, for purposes of adding the quencher (TAMRA) to the 3’ end
certain base pair additions were required (i.e. TAMRA requires T following). Results
indicated a lack of concentration-dependent fluorescent change, potentially resulting from
the quencher sequence. The quencher sequence was chosen based on functionality of the
5BIOTIN assay, however, shorter or longer sequences may be more suitable.
Finally, use of SMCC-linking chemistry was investigated. The thiol modified
assay lost over 98% in signal from washing which suggests that the immobilization
procedures were not successful. Immobilization issues could have resulted from the
operational variables including reconstitution of aptamer in purified water, and then
subsequent dilution with concentrated TCEP (to break disulfide bonds), instead of initial
reconstitution in TCEP.
Taken together, immobilization techniques investigated here were not shown to
be effective either in terms of sufficiently stable immobilization, or utility for detection of
OTA-induced fluorescence changes of the fluorophore/quencher aptamer pairs.
Subsequent studies, therefore, focused on solution-based approaches to the aptamer
assays.
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CHAPTER 4: APPLICATION OF APTAMER-BASED ASSAY FOR OTA TO
RELEVANT MATRICES
Introduction
The overarching aim of the study was development of aptamer-based methods to
quantitate OTA for application to relevant biological matrices. Included among the
matrices investigated were wine, as a relevant agricultural product, and blood serum in
relation to biomedical applications (i.e., detection of OTA exposure). The growing
market for wine consumption, as discussed in Chapter 1, has brought around an emerging
need for mycotoxin detection in wine samples. As a result of OTA in various agricultural
products, this and other mycotoxins have been found in human blood serum indicating
exposure, and furthermore, enabling investigation of the contribution of this exposure and assessment of exposure levels - relative to possible health effects (e.g.,
carcinogenicity).
Contamination of foodstuffs is highly dependent on the type of crop, and the
stages of processing. The two most common fungi species responsible for OTA
production are Aspergillus and Penicillium (11). During the wine-making process, the
key factors that influence OTA contamination is water availability, temperature, and pH
(6) (33). OTA has been detected in a variety of wines around the world, although most
recently, a study of U.S. wines showed both widespread occurrence, and high levels, of
OTA (17).
With respect to human exposure, and possible health effects, OTA has been
reported in blood serum, and linked to occurrence of negative health outcomes (e.g.,
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nephropathy, cancer). Khlifa et al. (2008), for example, conducted a study where 105
serum samples were taken from healthy patients, and 131 serum samples were taken from
nephropathic patients (reported to be related to OTA consumption), in Tunisia. Of the
105 healthy subjects, 28% tested positive for OTA with a mean of 0.49 ± 0.67 ng/mL. Of
the 131 nephropathic patients, 61% tested positive for OTA with a mean of 0.98 ± 1.15
ng/mL. The study concluded that chronic interstitial nephropathy appeared to be
associated with higher levels of OTA in the serum (34).
A variety of high-throughput approaches have been explored for effective
extraction of OTA from complex matrices such as wine and fetal bovine serum. Both of
these matrices present challenges. It has been previously shown, for example, that
phenolics present in wines may interfere with analyses, and specifically aptamer (and
immunoaffinity, e.g., ELISA) based techniques (15) as developed in the present study.
On the other hand, it has been shown that OTA binds readily to serum albumin proteins,
and represents a challenge to extraction techniques for this matrix. Alongside assessment
of the aptamer-based assay (developed in the current study) for quantitative analysis of
OTA in wine and blood serum, extraction methods for each matrix were evaluated by
conventional methods (i.e., HPLC-FD; De Jesus et al., 2018). Taken together, the goal
was to develop and assess the aptamer-based assay technique for application to these
relevant biological matrices.
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Materials and Methods
Materials
Fluorophore and quencher sequences were purchased from Integrated DNA
Technologies (IDT) in Coralville, Iowa with HPLC purification. The fluorophore
sequences are as follows: 5’-/Biotin-TEG/GAT CGG GTG TGG GTG GCG TAA AGG
GAG CAT CGG ACA-FAM-3’ (5BIOTIN), 5’-/56-FAM/ TGA TCG GGT GTG GGT
GGC GTA AAG GGA GCA TCG GAC A /3BioTEG/-3’ (3BIOTIN). The quencher
sequences are as follows: 5’-TAMRA-TGT CCG ATG C-3’ (5TAMRA) and 5’ CCC
ACA CCC GAT T /36-TAMSp/-3’ (3TAMRA).
Pierce™ Streptavidin Coated High Capacity 96-well plates (black/black) were
purchased from Thermo-Fisher Scientific, and stored at -20 ̊C. Chemicals including
magnesium chloride (MgCl2), tris(2-carboxyethyl) phosphine (TCEP), 4-(2hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), Trizma® hydrochloride (TrisHCl), potassium chloride (KCl), and calcium chloride (CaCl2) were purchased from
Sigma-Aldrich (St. Louis, MO). Water was purified with a Labconco Water Pro PS
system (18.2 megaohms). Ochratoxin A, 99+% was purchased from ACROS Organics™.
Oligonucleotides and OTA stored -20 ͦC. Eppendorf tubes (1.5 mL capacity) were
purchased from Aquarious. Centrifuge tubes (15 mL capacity) and autosampler vials (1.8
mL capacity) were purchased from VWR International. Autosampler 12 x 32 mm screw
top caps, and 200 µL glass inserts were purchased from Microsolv Technology
Corporation. Solvents including acetonitrile, acetic acid, water (HPLC grade),
chloroform, ethyl acetate, and hydrochloric acid were purchased from Fisher Chemical.
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Internal standard for HPLC, 7-methoxycoumarin, was purchased from SigmaAldrich (St.
Louis, MO).
Red wine (Yellowtail® Merlot 2015) was purchased from a local (Publix)
supermarket. As a proxy for blood serum, fetal bovine serum (from USDA approved
countries) was purchased from Sigma-Aldrich, and stored, until use, at -20 ̊C.
Assay Instrumentation
Measurements were taken on a Tecan Infinite® M1000 microplate reader with
excitation 495 nm and emission 520 nm. The gain was set to automatically adjust using
the well with the highest signal (100 nM aptamer only), and the z-position was
automatically set based on scanning volume in wells. Additionally, some measurements
were taken on a Biotek Synergy 2 plate reader, whereby the filter was set to 485/20 nm
excitation and 528/20 nm emission. The gain was, likewise, measured as the well with
the highest signal (100nM aptamer only), and subsequently used throughout the
procedure.
Aptamer Assay Procedure
Aptamer assays were generally performed as previously described (in Chapter 2)
with modifications, as discussed below. Briefly, an equivalent volume of duplex was
prepared for each well, and consisting of 0.5 µL of fluorophore strand (10uM) and 0.5 µL
of quencher strand (20uM) added) to 48 µL of binding buffer (in a 500 µL Eppendorf
tube). The duplex was heated to 88 °C for 5 minutes, and cooled at room temperature for
30 minutes. The duplex (49 µL) was added to the 96-well plate, and initial measurements
were taken in 1-minute intervals for 10 minutes (stability of signal). Measurements were
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taken in 1-minute intervals over 10 minutes (n = 10). Next, OTA-containing sample (i.e.,
spiked wine or serum, or extracts) was added in 1 µL to each well to give appropriate
concentration ranges (i.e., 1 µL diluted in 49 µL of assay buffer). Measurements were
taken in 1-minute intervals over 10 minutes, with the first measurement made within 60
seconds of addition of OTA to the assay.
Wine
A variety of methods were investigated for extraction of OTA, and introduction
into assays. Initially, spiked wine was added directly to the assay, however, to mitigate
potential interferences other methods were explored. One method included simple
dilution: 450 µL of red wine was diluted to 45 mL in Tris binding buffer, creating a 1%
wine solution, to dilute possibly interfering species (e.g., phenolics). Secondly, wine was
extracted using a previously developed, De Jesus et al. (2018), liquid/liquid extraction
(LLE) method specifically using chloroform, and reconstitution of extracted OTA in
either binding buffer or organic solvent (i.e., methanol).
Recognizing that phenolics present in wines may interfere with aptamer-based
detection, a method to remove phenolics from wine was investigated. Specifically, the
addition of polyvinylpyrollidone (PVP) to wine samples as previously reported (15).
Briefly, 400 µL of a 20 ug/mL solution of PVP-40 in water was added to a 2 mL aliquot
of wine, shaken at room temperature for 5 minutes, centrifuged for 10 minutes at 6000
rpm, pH was adjusted to 7.5 by addition of 1M sodium hydroxide (NaOH), and filtered
with 0.22 micron filter (15).
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Fetal Bovine Serum
Fetal bovine serum (FBS) was employed to investigate the ability to extract,
recover and measure OTA using the aptamer assay. Aliquots of FBS were portioned and
stored in 15-mL polypropylene centrifuge tubes for subsequent studies. Sub-aliquots of
FBS were spiked with relevant concentrations of 0, 50, 250, 500 and 1000 ng/mL OTA
(0, 1, 5, 10, 20 final concentration in assay with 1:50 dilution) in methanol.
Two extraction methods for serum were investigated for application to the
aptamer assays. The first method utilized a simple LLE with chloroform whereby a 500
µL aliquot of OTA-spiked serum was extracted with 1mL of chloroform, and subsequent
operating procedures similar to that used for LLE of wine (i.e. vortex, remove
supernatant, dry, reconstitute). After verifying by HPLC-FD that this method was
insufficient to extract OTA from serum a multi-step extraction, previously reported (35),
was explored. In this method, 1mL of serum spiked with OTA concentration was
combined with 5 mL of a 1:1 mixture of 0.2 M magnesium chloride (MgCl2) and 0.1 M
hydrochloric acid (HCl), and mixed for 1 minute (35). After mixing, 3 mL of chloroform
was added to the mixture, shaken, and centrifuged at 768xg RCF for 5 minutes. The
bottom chloroform layer was removed and dried down under a stream of air. The water
layer was removed and the extraction was conducted again by adding 3 mL of
chloroform. The chloroform layer was removed and added to the other, dried down under
a stream of air, and reconstituted with 1 mL of methanol.
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HPLC-FD of OTA
To evaluate the effectiveness of extraction techniques for wine and serum, a
previously described HPLC-FD method, De Jesus et al. (2018), was employed to quantify
OTA. For analyses, samples were reconstituted in either binding buffer or methanol, and
effectiveness of both were subsequently compared by HPLC-FD. Calibration curves,
covering a relevant range of OTA concentrations, were generated. Specifically, OTA was
reconstituted and diluted in 200 µL of HPLC mobile phase (i.e., water, acetonitrile and
2% glacial acetic acid, 49.5:49.5:1), and transferred to HPLC amber vials containing 200
µL inserts.
For HPLC-FD measurement of OTA, a Shimadzu Prominence UFLC system with
an autosampler and fluorescence detector, and equipped with a Sonoma C18(2) column
(5µm, 100 Å pore size, 250mm x 4.6mm, ES Industries, West Berlin, NJ, USA), was
used. The injection volume was 20 µL, and separation was achieved by an isocratic
elution (water, acetonitrile and 2% glacial acetic acid, 49.5:49.5:1) at 1.0 mL/min.
Fluorescent detection was conducted using 333nm excitation and 460nm emission.
HPLC-UV/Vis/FD of Phenolics
To assess phenolics in wine and potential application of PVP for removal of
phenolics(see above), in HPLC-UV/Vis/FD technique was modified from RodriguezDelgado et al. (2001) and employed. Briefly, 1 mL of wine was transferred to a 15 mL
polypropylene centrifuge tube to which 1 mL of diethyl ether was added, followed by
vortexing (10 s), and equilibration (10 min). The organic supernatant layer was removed,
and dried under a stream of air. The phenolic extract was reconstituted in methanol: water
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(1:1), and analyzed by HPLC-UV/VIS/FD using a Waters Nova-Pak® C16 column
(4µm, 3.9 x 300mm, Ireland). Analytical separation was achieved using a gradient elution
of solvent A (methanol:acetic acid:water, 10:2:88) and solvent B (methanol:acetic
acid:water, 90:2:8) as follows: 0 to 15 min, 100% to 85% solvent A; 15 to 25 min, 85%
to 50% solvent A; 25 to 34 min, 50% to 30% solvent A. Phenolics were measured using a
photodiode array detector (200-450nm), and fluorescence detection (excitation 278nm,
emission 360nm), as described (36).
Calculations and Statistical Analysis
All data were normalized, subtracting the buffer control signal, therefore,
reducing the percent change in fluorescent intensity influenced by the buffer composition.
The percent change in fluorescent intensity (RFU) was calculated as [(finalinitial)/initial]*100. The LOD was calculated as 3*(std. error of y-values/slope) and the
LOQ as 10*(std. error of y-values/slope). The reproducibility and repeatability were
measured by the %RSD or the (standard deviation/mean) *100. Recoveries were
calculated based on the linear regression of ΔRFU versus OTA concentration from
calibration curves (RFU= m [OTA] + b, where m and b are slope and y-intercept of the
regression), and percent recovery was calculated based on the measured versus the
actual concentration of OTA. Statistical tests, including ANOVA and t-tests, were
conducted using Excel (output is given in Appendices).
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Results
OTA in Wine
Ability of the aptamer-based assay to measure OTA in wine was assessed in
toxin-spiked wine samples. The wine used in these studies was confirmed by HPLC-FD
not to have OTA aside from that spiked into aliquots. The wine was subsequently spiked
with OTA at a concentration range of 0, 50, 250, 500, 1000, and 1500 ng/mL (giving
final concentrations, after 1:50 dilution, of 0, 1, 5, 10, 20, and 30ppb). Initially, aliquots
(1 µL) of spiked wine samples were diluted into test wells. No clear concentration
dependent increase in fluorescence was observed, although, both 20 and 30 ng/mL have
positive changes (Figure 14).

Figure 14: Wine samples (neat) spiked with OTA added to wells in 1 µL volumes
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As an alternative approach, wine was subsequently diluted to 1% with binding
buffer, and then spiked with varying OTA levels, which were subsequently diluted once
more, upon addition to 96-well plate. Back calculating, 5 ng/mL would, therefore,
correspond to a 500 ng/mL concentration of OTA in the wine. Upon addition of 10 µL of
1% wine with no OTA, there was still detectable background signal. However, there
appears to be a concentration-dependent increase in the measured fluorescent response
(Figure 15).

Figure 15: Wine diluted 100 fold with binding buffer and spiked with OTA

Next, wine samples were spiked and extracted following previously developed
(De Jesus et al., 2018) method of LLE. Initialy, extract was reconstituted and
concentrated with 100 µL of binding buffer. However, no concentration-dependent
increase in fluorescence was discernible, and very high error (i.e., standard deviation) in
the response was observed (Figure 16).
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Figure 16: Extracted OTA using liquid/liquid extraction added in 10 µL volumes

To investigate the potential interference of phenolics present in wine and extracts,
PVP was added to wine to remove potentially interfering phenolics as previously
described as a “fining” method for wine (15), (37). Addition of PVP to wine showed no
improvement of the concentration-dependency of the fluorescence response for either
directly diluted wine or wine extracts (Figure 17).

Figure 17: In solution assay using PVP/wine/chloroform extract method
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To further assess the ability of PVP to reduce phenolics, HPLC-UV/Vis/FD was
utilized to analyze PVP treated and untreated wine. As shown in Figure 18, the addition
of PVP to wine had no discernible effects on the levels or composition of the major
phenolic components.

7-MC

7-MC

Figure 18: Individual chromatograms for phenolic separation with PVP extracted wine

Finally, to evaluate the effect of the solvent used to reconstitute OTA in wine
extracts, the use of binding buffer (as initially employed) was compared, by HPLC-FD, to
methanol as a recovery solvent. As shown in Figure 19, methanol was clearly a more
effective solvent for recovery of OTA following extraction (corresponding
chromatograms are given in Appendix 4 (Figure 25 and 26). Recoveries for methanol
were approximately 78-90%, whereas when reconstituted in binding buffer, only 0-4% of
OTA was recovered (Table 3).
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Figure 19: Comparison of wine reconstitution with OTA calibration curve
Table 3: Recoveries of wine in methanol and binding buffer

Recoveries %
Wine Meth
Wine BB

Concentration (ng/mL)
50
250
500
1000
78.7374 82.1552 89.6555 87.3264
0 2.68792 2.6199 3.76197

Based on the obvious improvement of OTA recovery using methanol, the aptamer
assay was repeated with extracts of wine reconstituted in methanol. A clear
concentration-dependent response was observed, and a highly linear relationship (R2=
0.97) between fluorescent change and OTA concentration was found in the relevant range
of 0-20ppb (Figure 20). The calculated LOD and LOQ were found to be 4.4 ng/mL and
14.7 ng/mL, respectively, and higher than observed for OTA alone (See Chapter 2).
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Figure 20: Bar graph showing increasing change in fluorescent intensity with increasing concentration,
with calibration including dynamic range (0-20ng/mL)

OTA in Serum
As a proxy for blood serum, commercially available FBS was spiked with various
concentrations of OTA (from 0, 50, 250, 500, 1000 ng/mL, and corresponding to final
concentrations of 0, 1, 5, 10, 20 ng/mL in the assays). As for serum, spiked FBS (1µL)
was initially diluted directly into assay wells. As shown in Figure 21, no concentrationdependent increase in fluorescent change was observed.
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Figure 21: Change in fluorescent intensity upon addition of spiked BFS in solution-based assays for 2
replicates

Extraction of OTA-spiked serum was investigated. Initially, a simplified LLE
(based on that used for wine) method with chloroform extraction and reconstitution in
binding buffer, was evaluated. As shown in Figure 22, there was clearly no
concentration-dependent increase in fluorescent response in the assay. Measurement of
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OTA in serum extracts (redissolved in binding buffer) suggested very little recovery by
this technique.

Figure 22: Change in fluorescent intensity upon addition of extracted BFS spiked samples.

It has, in fact, been found in multiple studies, Grajewski et al. (2012); Khlifa et al.
(2010); Malir et al. (2013), that OTA binds readily to proteins (i.e., albumin) in serum.
Accordingly, an alternative extraction method was investigated, and specifically, a
previously reported method, Grajewski et al. (2012), which utilizes addition of MgCl2
and acidification (with HCl) prior to chloroform extraction. Samples were reconstituted
in either binding buffer or methanol and analyzed for OTA by HPLC-FD to compare
recoveries (Figure 23). Observed recovery of OTA by either binding buffer or methanol
was, however, quite low; although, the use of methanol was more effective (12-27%)
compared to binding buffer (1-3%) (Figure 23 and Table 4).
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Figure 23: Comparison of serum reconstitution with OTA calibration curve
Table 4: Recoveries of serum in methanol and binding buffer

Recoveries %
Serum Meth
Serum BB

Concentration (ng/mL)
50
250
500
1000
12.4381 14.2197 26.8138 24.9787
2.40254 1.26028 2.30345 3.11586

The aptamer assay was repeated with serum that was extracted (with addition of
MgCl2 and acidification), and specifically reconstituted in methanol. A linear
concentration-dependent increase in fluorescent response was observed (R2=0.93) over
the relevant range of 0-20 ppb, however, calculated LOD (8.0ng/mL) and LOQ (26.8
ng/mL) were higher than observed for wine (Figure 24). Corresponding chromatograms
of samples in binding buffer and methanol are given in Appendix 4 (Figure 27 and 28).

50

*

*
*
*

Figure 24: Bar graph showing increasing change in fluorescent intensity with increasing concentration,
with calibration including dynamic range (0-20ng/mL)

Discussion
Toward adaptation of the aptamer-based assay, previously developed in this
research, for high-throughput analysis of OTA in relevant biological matrices, the assay
was evaluated with respect to wine, as a relevant agricultural product, and blood serum
(i.e., FBS), as a biomedically relevant matrix. These matrices were found to present
multiple challenges to the proposed assay approach. Although some of these challenges
were overcome by relatively simple extraction and other sample preparation techniques, a
number of limitations to these methods were found.
OTA in Wine
Several strategies for assay-based analysis of OTA in wine were explored
including direct introduction into assays, dilution (in assay buffer) prior to assays,
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removal of interfering phenolics (by PVP prior to assays), and finally simplified
extraction and recovery of OTA from wine. Direct introduction of wine did not provide a
concentration-dependent response in the assays (Figure 14). It has been previously
reported, Vidal et al. (2012); Mavrikou et al. (2018), that phenolics (e.g., flavonoids,
phenolic acids) from grapes which contribute both “color” and other characteristics to the
wine that can interfere with aptamer-based detection, and in fact, similar affinity-based
methods (e.g., ELISA). Interference, in the current context, could include both crossreactivity of aptamers with phenolics, and possible overlap in the fluorescence
excitation/emission wavelengths between phenolics and fluorophore (i.e., FAM) used in
the assay. With respect to the latter point, anthocyanins, which are primary phenolics
associated with wine color, absorb in the visible range (465-560nm), as well as UV range
(265-275nm) (38), and would likely interfere with excitation/emission wavelengths used
in the assay (i.e., 495 and 520nm, respectively). The use of PVP which has been shown to
bind and remove phenolics was investigated as a means to reduce these interfering
compounds; however, subsequent HPLC-FD analysis suggested little capacity to remove
phenolics.
Dilution of wine (in binding buffer) prior to assays did enable relatively precise
concentration-dependent response in the assay (Figure 15). However, this approach
requires a 100-fold dilution of wine and would likely limit the effectiveness of the assay
with respect to environmental and biomedically relevant OTA concentrations which are
typically in low (0-10) ppb ranges. In the case of wines, for example, the currently
established EU regulatory limit is 2ppb.
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Finally, extraction of OTA from wine was investigated and specifically a
simplified LLE method previously developed for application to HPLC-FD (17). In
addition, the suitability of recovery solvent (use to reconstitute extracts) was assessed. It
was found that a simple LLE with chloroform was, when coupled to OTA reconstitution
in methanol, relatively effective in the recovery of OTA from wine (Figure 19), and
furthermore, enabled concentration-dependent fluorescent response in the aptamer assay
(and thus, potentially quantitative application) for OTA in wine (Figure 20). However,
sensitivity was approximately 2-fold lower, based on calculated LOD/LOQ, compared to
results observed for OTA alone (in development of the assay; See Chapter 2).
OTA in Serum
As a biomedically and forensically relevant sample application, blood serum
(FBS) was evaluated as a sample matrix. OTA has been found in human serum in
association with exposure to OTA via contaminated food or other agricultural products
and in relation to asserted human health effects (e.g. nephropathy, cancer) (1), (5), (9),
(10), (31).
Similar to wine, introduction of OTA-spiked FBS by both direct dilution into
assays, and following solvent extraction, were evaluated. Direct introduction (dilution)
into assays was clearly unable to illicit a concentration-dependent (and, therefore,
quantitative) response in assays (Figure 21). Although a relatively simple solvent (i.e.
LLE) based method for extraction was developed, and found to improve recovery and
assay performance including a concentration-dependent response (Figure 24), the
calculated LOD/LOQ suggest a highly reduced sensitivity of the assay (with a 4-fold
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decrease, compared to OTA alone; See Chapter 2). This is likely due to the low recovery
of OTA from serum (Figure 23 and Table 4). Indeed, previous studies have shown that
OTA readily binds to albumin in serum and likely limits the recovery in the extraction
and assay developed here. Future studies should focus on refinement of extraction
techniques to overcome this limitation, and otherwise, improve sensitivity of the assay.
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CHAPTER 5: CONCLUSION
Ochratoxin A is a widespread and potent mycotoxin that contaminates a wide
range of crop plants, and thus, foods and other agricultural products (29) (39) (40) (See
Chapter 1). The current research focused on development of novel and sensitive aptamerbased method for detection and quantitation of OTA in relevant sample matrices.
Specifically, the approach developed herein utilized a fluorescence quenching of
complementary oligonucleotide aptamers, and more specifically, adaptation of this
approach to a high-throughput (e.g., 96-well plate) format. A solution-based aptamer
assay showed promising results (Chapter 2) with a calculated LOD of approximately 2.7
ng/mL and LOQ of 8.9 ng/mL which would potentially enable detection and quantitation
in parts-per-billion concentration ranges relevant to applications for assessment of OTA
in agricultural products, medically and/or forensically relevant samples.
Techniques for immobilization of aptamers in multiwell plate formats were
investigated (Chapter 3), specifically as a means to integrate sample “clean-up” (via
“target trapping” and/or removal interfering species by washing steps). Approaches
included the use of biotin/streptavidin binding to test plates, and SMCC-based chemistry
for covalent binding to plates. None of the approaches provided reproducible, or even
concentration-dependent, responses in assay upon addition of OTA. Among other
explanations (e.g., apparent lack of effective immobilization by SMCC), it was concluded
that limitations of fluorescence detection in assays may relate to the optical properties
and specifically efficacy of plate readers for fluorometric measurements, of surface

55

immobilized nature of the aptamers. Future studies will need to explore this
methodological aspect.
Application of the aptamer-based assay was evaluated for relevant matrices
including wine and serum (Chapter 4). It was found that extraction from either matrix
was required. Extraction techniques that were applied did enable quantitative utility of
the assay. However, sensitivity in both cases was lower than expected (from assay
development studies; Chapter 2). Calculated limits of detection, and quantitation, were in
the ppb range (i.e., LOD= 4.4 ng/mL and 8.0 ng/mL, respectively, for wine and serum),
however, were lower (2- and 4- fold respectively, for wine and serum) than OTA alone.
This is likely due to the relatively low recovery of OTA (> 90% and > 25% for wine and
serum, respectively) afforded by solvent extraction and subsequent reconstitution steps.
Recommendations for future work would include optimization of extraction and
sample preparation methods for wine and serum (and other future applications). In
addition, the limited potentially “optimistic” result for test formats based on immobilized
aptamers would also suggest future value, continue investigation of this approach which
would, likewise, potentially improve efficacy of the assay to agricultural, biomedical,
forensic, and other (e.g., environmental) applications.
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Appendix 1
Name/ Purpose
SOLUTION

5BIOTIN/5TAMRA

3BIOTIN/ 3TAMRA

Cy5/IAbRQ

Cy5/IAbRQ
BIOTINYLATED

THIOL

MICROCYSTIN

Fluorophore
5’- GAT CGG GTG TGG
GTG GCG TAA AGG
GAG CAT CGG ACA /36FAM/-3’
5’-/5BiotinTEG/ GAT
CGG GTG TGG GTG
GCG TAA AGG GAG
CAT CGG ACA /36FAM/-3’
5’/56-FAM/TGA TCG
GGT GTG GGT GGC
GTA AAG GGA GCA
TCG GAC A/3BioTEG/-3’
5’- GAT CGG GTG TGG
GTG GCG TAA AGG
GAG CAT CGG ACA
/3Cy5Sp/-3’
5’-/5BiotinTEG/ GAT
CGG GTG TGG GTG
GCG TAA AGG GAG
CAT CGG ACA /3Cy5Sp/3’
5’-/5ThioMC6-D/ GAT
CGG GTG TGG GTG
GCG TAA AGG GAG
CAT CGG ACA /36FAM/-3’
5’- GGC GCC AAA CAG
GAC CAC CAT GAC
AAT TAC CCA TAC
CAC CTC ATT ATG CCC
CAT CTC-/36-FAM/-3’
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Quencher
5’-/55-TAMK/ TGT CCG
ATG C-3’

5’-/55-TAMK/ TGT CCG
ATG C-3’

5’ CCC ACA CCC GAT
T/36-TAMSp/-3’

5’-/IAbRQ/ TGT CCG
ATG C-3’

5’-/IAbRQ/ TGT CCG
ATG C-3’

5’-/55-TAMK/ TGT CCG
ATG C-3’

5’-/55TAMK/ GCG GAG
ATG G- 3’

Appendix 2
Table 5: ANOVA to determine significant differences between the percent change in fluorescent intensity
for spiked OTA concentrations of 0, 1, 2, 5, 10, 15, and 20 ng/mL.

Table 6: t-test difference between 0 and 1 ng/mL (left) and t-test difference between 1-5 ng/mL (right)
t-Test: Two-Sample Assuming Equal Variances

t-Test: Two-Sample Assuming Equal Variances

0ppb
1ppb
Mean
6.05484 7.654094
Variance 1.786239 0.24914
Observations
5
5
Pooled Variance
1.017689
Hypothesized Mean0 Difference
df
8
t Stat
-2.50657
P(T<=t) one-tail
0.018283
t Critical one-tail
1.859548
P(T<=t) two-tail
0.036566
t Critical two-tail
2.306004

1ppb
5ppb
Mean
7.654094 13.34768
Variance
0.24914 0.175141
Observations
5
5
Pooled Variance
0.21214
Hypothesized Mean0 Difference
df
8
t Stat
-19.5454
P(T<=t) one-tail
2.44E-08
t Critical one-tail
1.859548
P(T<=t) two-tail
4.88E-08
t Critical two-tail
2.306004
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Table 7: t-test difference between 1 and 15 ng/mL (left) and t-test difference between 1 and 20ng/mL (right)

t-Test: Two-Sample Assuming Equal Variances

t-Test: Two-Sample Assuming Equal Variances

15ppb
1ppb
Mean
12.76976 7.654094
Variance 29.25187 0.24914
Observations
5
5
Pooled Variance
14.7505
Hypothesized Mean0 Difference
df
8
t Stat
2.10605
P(T<=t) one-tail
0.034146
t Critical one-tail
1.859548
P(T<=t) two-tail
0.068292
t Critical two-tail
2.306004

20ppb
1ppb
Mean
17.10864 7.654094
Variance 2.030175 0.24914
Observations
5
5
Pooled Variance
1.139657
Hypothesized Mean0 Difference
df
8
t Stat
14.00308
P(T<=t) one-tail
3.28E-07
t Critical one-tail
1.859548
P(T<=t) two-tail
6.56E-07
t Critical two-tail
2.306004
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Appendix 3
Table 8: ANOVA to determine significant differences between the percent change in fluorescent intensity
for various spiked OTA concentrations of 0, 1,5, 10, and 20 ng/mL for the 5BIOTIN assay.

Anova: Single Factor
SUMMARY
Groups
Count
Sum
Average Variance
0ppb
2 25.8528 12.9264 13.20752
1ppb
2 34.85917 17.42958 31.01861
5ppb
2 26.22408 13.11204 2.276456
10ppb
2 27.76077 13.88038 15.95848
20ppb
2 62.94928 31.47464 341.9591

ANOVA
Source of VariationSS
Between Groups
496.4382
Within Groups
404.4202
Total

900.8584

df

MS
F
P-value
F crit
4 124.1096 1.534414 0.321066 5.192168
5 80.88403
9
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Table 9: ANOVA to determine significant differences between the percent change in fluorescent intensity
for various spiked OTA concentrations of 0, 1,5, 10, and 20 ng/mL for the 3BIOTIN assay.

Anova: Single Factor
SUMMARY
Groups
Count
Sum
Average Variance
0PPB
2 16.66571 8.332857 6.168985
1PPB
2 16.10863 8.054316 4.607152
5PPB
2 19.63154 9.815768 0.160996
10PPB
2 25.44309 12.72155 9.580523
20PPB
2 27.08687 13.54343
7.4149

ANOVA
Source of VariationSS
Between Groups
50.6872
Within Groups
27.93256
Total

78.61976

df

MS
F
P-value
F crit
4 12.6718 2.268285 0.19651 5.192168
5 5.586511
9
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Table 10: Two factor ANOVA output comparing Tris and HEPES buffer for 5BIOTIN assay

Anova: Two-Factor With Replication
SUMMARY0PPB

0.5PPB

1PPB

2PPB

5PPB

Total

Tris

Count
Sum
Average
Variance

2
2
2
2
2
10
15.14871 15.96287 16.24895 22.35158 16.57895 86.29105
7.574355 7.981435 8.124473 11.17579 8.289474 8.629105
1.55071 15.71641 0.963011 19.0507 4.124713 6.46452

HEPES

Count
Sum
Average
Variance

2
2
2
2
2
10
19.74325 16.14522 20.13756 22.63747 19.27326 97.93676
9.871623 8.072612 10.06878 11.31874 9.636628 9.793676
2.562701 17.18127 13.5098 16.09151 1.892931 6.891866

Total

Count
Sum
Average
Variance

4
4
4
4
4
34.89196 32.10809 36.3865 44.98905 35.8522
8.722989 8.027024 9.096625 11.24726 8.963051
3.130283 10.96867 6.084378 11.72088 2.610823

ANOVA
Source of VariationSS
Buffer
6.781122
Concentration
23.44351
Interaction 4.12021
Within
92.64375
Total

126.9886

df
1
4
4
10

MS
F
P-value
F crit
6.781122 0.731957 0.412279 4.964603
5.860879 0.632625 0.650574 3.47805
1.030052 0.111184 0.975748 3.47805
9.264375

19
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Appendix 4
Table 11: t-test difference between 20 and 30 ng/mL spiked wine in solution-based assay

t-Test: Two-Sample Assuming Equal Variances
30PPB
20PPB
Mean
24.04006 8.409634
Variance 118.9755 78.43149
Observations
2
2
Pooled Variance
98.70349
Hypothesized Mean0 Difference
df
2
t Stat
1.573274
P(T<=t) one-tail
0.128149
t Critical one-tail
2.919986
P(T<=t) two-tail
0.256299
t Critical two-tail
4.302653

Figure 25: Chromatogram of wine reconstituted in binding buffer

69

Figure 26: Chromatogram of wine reconstituted in methanol

Figure 27: Chromatogram of serum reconstituted in binding buffer

Figure 28: Chromatogram of serum reconstituted in methanol
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